 |
 An International Journal for Lung Cancer and other thoracic malignancies
Editor-in-Chief:
Rolf A. Stahel
See editorial board for all editors information
See  http://ees.elsevier.com/lungcancer for details on how to submit a manuscript online.
Description
Lung Cancer aims to provide individuals or organisations with the most recent information on lung cancer
and other thoracic malignancies. The Journal publishes original research and review articles on clinical and basic science aspects of
topics represented by the fields of interest of Lung Cancer (prevention, epidemiology and etiology, basic biology, pathology, clinical
assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities, outcomes).
Bibliographic & ordering information
ISSN: 0169-5002
Imprint: ELSEVIER
Commenced publication 1986
Subscriptions for the year 2009,
Volumes 63-66,
12 issues
Institutional online access: ScienceDirect eSelect
For purchase of online access to this journal on ScienceDirect.
Institutional price: Order form
USD 2,736 for all countries except Europe, Japan and Iran
JPY 286,400 for Japan
EUR 2,446 for European countries and Iran
Personal price: Order form
USD 121 for all countries except Europe, Japan and Iran
EUR 109 for European countries and Iran
JPY 14,300 for Japan
Personal price UK: Order form
GBP 75
Conditions of sale & ordering procedures, and links to our regional sales offices.
For an overview of recently-dispatched issues, see the Journal issue
dispatch dates
Audience
Clinical Oncologists, Internists, Radiologists, Radiotherapists, Thoracic Surgeons, Pulmonary Disease Physicians, Pathologists, Epidemiologists, Public Health Specialists.
Impact factor of this journal
2007: 3.455
© Journal Citation Reports 2008, published by Thomson Reuters
063/631
Last update: 4 Sep 2008
|
|
| |
